A Study of BR1400-1, BR1400-2, BR1400-3, BR1400-4, and BR1400-5 in Patients With Essential Hypertension

NCT07373613 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

330

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: BR1400-1
DRUG: BR1400-2
DRUG: BR1400-3
DRUG: BR1400-4
DRUG: BR1400-5
DRUG: BR1400-A
DRUG: BR1400-B
DRUG: BR1400-C

Sponsor

Boryung Pharmaceutical Co., Ltd